- 51-200 Employees
- Based in Alameda, California
Exelixis, Inc. engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer, metabolic, and cardiovascular disorders. The company's compounds primarily target multiple receptor tyrosine kinases simultaneously.
Most Recent Responsibility Report
2022 Corporate Values & Sustainability Report
Our service enables potential investors to review the most recent and archived Exelixis, Inc. Sustainability Report, Exelixis, Inc. Corporate Social Responsibility Report, Exelixis, Inc. CSR Report, Exelixis, Inc. Corporate Responsibility, Exelixis, Inc. CR Report, Exelixis, Inc. Citizenship Report, Exelixis, Inc. ESG Report, and Exelixis, Inc. Environmental Report online.